Prophylactic intranasal administration of a TLR2 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model

MLA

Nadina Wand, et al. Prophylactic Intranasal Administration of a TLR2 Agonist Reduces Upper Respiratory Tract Viral Shedding in a SARS-CoV-2 Challenge Ferret Model. Sept. 2020. EBSCOhost, https://doi.org/10.1101/2020.09.25.309914.

APA

Nadina Wand, Catherine M K Ho, Susan A. Fotheringham, Stephen Thomas, Robert J. Watson, Pamela C. Proud, Gillian S. Slack, Brendon Y. Chua, Francesca A. Mercuri, Marilyn Aram, Miles W. Carroll, Daphne Tsitoura, Kevin R. Bewley, Paul Yeates, Kathryn A. Ryan, Nathan W. Bartlett, Stuart D. Dowall, Emma Rayner, Breeze E. Cavell, … Rebecca Cobb. (2020). Prophylactic intranasal administration of a TLR2 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model. https://doi.org/10.1101/2020.09.25.309914

Chicago

Nadina Wand, Catherine M K Ho, Susan A. Fotheringham, Stephen Thomas, Robert J. Watson, Pamela C. Proud, Gillian S. Slack, et al. 2020. “Prophylactic Intranasal Administration of a TLR2 Agonist Reduces Upper Respiratory Tract Viral Shedding in a SARS-CoV-2 Challenge Ferret Model,” September. doi:10.1101/2020.09.25.309914.